Full Text View
Tabular View
No Study Results Posted
Related Studies
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction
This study has been completed.
Study NCT00037804   Information provided by Pfizer
First Received: May 21, 2002   Last Updated: August 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Unspecified Adult Solid Tumor
Chemotherapy
Liver Dysfunction
Neoplasms, Solid Tumor
Additional conditions recognized in this trial
Liver Diseases
Neoplasms
More general conditions related to this trial
Digestive System Diseases
Interventions listed in this trial
Irinotecan
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services